Yes, Japan conducts joint drug quality audits with other regulatory authorities. Through international collaborations like the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and partnerships with agencies such as the U.S. FDA and EMA, Japan enhances drug quality standards, ensuring safety and efficacy in the global pharmaceutical market.